GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection
Public ClinicalTrials.gov record NCT01434498. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of GS-5885, GS-9451, Tegobuvir and Ribavirin; GS-5885, GS-9451 and Tegobuvir; GS-5885, GS-9451 and Ribavirin in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b HCV Infection (Protocol No. GS US 248 0132)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of GS-5885, GS-9451, Tegobuvir and Ribavirin; GS-5885, GS-9451 and Tegobuvir; GS-5885, GS-9451 and Ribavirin in Interferon Ineligible or Intolerant Subjects with Chronic Genotype 1a or 1b HCV Infection.
Study identification
- NCT ID
- NCT01434498
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 163 participants
Conditions and interventions
Conditions
Interventions
- GS-5885 tablet Drug
- GS-9451 tablet Drug
- tegobuvir capsule Drug
- ribavirin tablet Drug
- placebo matching ribavirin tablet Drug
- placebo matching tegobuvir capsule Device
Drug · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2011 (Type not available)
- Primary completion
- Jan 2013 (Actual)
- Completion
- Jan 2013 (Actual)
- Last update posted
- Dec 20, 2013
2011 – 2013
United States locations
- U.S. sites
- 36
- U.S. states
- 18
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Liver Institute | Beverly Hills | California | 90211 | — |
| SCTI Research Foundation Liver Center | Coronado | California | 92118 | — |
| Scripps Clinic | La Jolla | California | 92037 | — |
| University of California, San Diego | La Jolla | California | 92161 | — |
| Kaiser Permanente Medical Center | Los Angeles | California | 90027 | — |
| Lightsource Medical | Los Angeles | California | 90036 | — |
| Medical Associates Research Group, Inc. | San Diego | California | 92123 | — |
| Kaiser Permanente | San Diego | California | 92154 | — |
| California Pacific Medical Center | San Francisco | California | 94115 | — |
| University of Colorado | Aurora | Colorado | 80045 | — |
| University of Miami, Center for Liver Diseases | Miami | Florida | 33136 | — |
| Orlando Immunology Center (ACH) | Orlando | Florida | 32803-1851 | — |
| Gastrointestinal Specialists of Georgia, PC | Marietta | Georgia | 30060 | — |
| Indianapolis Gastroenterology Research Foundation | Indianapolis | Indiana | 46237 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Johns Hopkins University | Lutherville | Maryland | 21093 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Beth Israel Deconess Medical Center | Boston | Massachusetts | 02215 | — |
| The Research Institute | Springfield | Massachusetts | 01105 | — |
| Henry Ford Health System | Novi | Michigan | 48377 | — |
| Saint Michael's Medical Center | Newark | New Jersey | 07102 | — |
| Weill Cornell Medical College | New York | New York | 10021 | — |
| Asheville Gastroenterology Associates, P.A. | Asheville | North Carolina | 28801 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | — |
| University Gastroenterology | Providence | Rhode Island | 02905 | — |
| Gastro One | Germantown | Tennessee | 38138 | — |
| The North Texas Research Institute | Arlington | Texas | 76012 | — |
| The University of Texas Medical Branch | Galveston | Texas | 77555 | — |
| The University of Texas Health Sciences Center at Houston | Houston | Texas | 77030 | — |
| Alamo Medical Research | San Antonio | Texas | 78215 | — |
| Inova Fairfax Hospital Center for Liver Diseases | Falls Church | Virginia | 22042 | — |
| Bon Secours St. Mary's Hospital of Richmond, Inc. | Newport News | Virginia | 23602 | — |
| Digestive and Liver Disease Specialists | Norfolk | Virginia | 23502 | — |
| Virginia Mason Medical Center | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01434498, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 20, 2013 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01434498 live on ClinicalTrials.gov.